Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Vol. 3, 28 April 2023
* Author to whom correspondence should be addressed.
Brain tumors are difficult to be totally cured , and also associated with high rates of mortality and morbidty, therefore the therapy is always a hot issue.This review introduces glioma treatment techniques through literature summarization and qualitative analysis. According to the data, technologies that can improve median survival and potentially substitute contemporary techniques during the treatment, including photon therapy, and hyperthermia. Moreover, some techniques can improve the accuracy and safety of surgical, such as Intraoperative Neuromonitoring and Neuronavigation During Resection. Other treatment methods, such as gene therapy and immunotherapy, are feasible based on their principles. However, their current effects have not reached expectations, so they are not widely used at this stage, and further innovation and experimental proof are needed.
glioma surgery, gioma, chemotherapy, radiotherapy, treatment
1. Northcott P.A., Robinson G.W., Kratz C.P., Mabbott D.J., Pomeroy S.L., Clifford S.C., Rutkowski S., Ellison D.W., Malkin D., Taylor M.D. Medulloblastoma. Nat. Rev. Dis. Prim. 2019;5:1–20. doi: 10.1038/s41572-019-0063-6
2. Daumas-Duport C, Scheithauer B, O’Fallon J, Kelly P (1988) Grading of astrocytomas. A simple and reproducible method. Cancer 62:2152–2165
3. Khoshnevisan A, Allahabadi N S. Neuronavigation: principles, clinical applications and potential pitfalls[J]. Iranian Journal of Psychiatry, 2012, 7(2): 97.
4. Mitsui T, Fujii M, Tsuzaka M, Hayashi Y, Asahina Y, Wakabayashi T. Skin shift and its effect on navigation accuracy in image-guided neurosurgery. Radiol Phys Technol. 2011;4:37–42.
5. You H, Qiao H. Intraoperative Neuromonitoring During Resection of Gliomas Involving Eloquent Areas[J]. Frontiers in Neurology, 2021, 12: 952.
6. Uddin M M, Hussain S Z M, Sarfaraz A, et al. A review of conservative and latest techniques of treatment of glioma[J]. Annals of Medical and Health Sciences Research, 2018.
7. Li W, Zhang R, Yang J and Wang R: Efficacy and prognosis of surgery combined with 125I seed implantation in treatment of recurrent glioma. Oncol Lett 14: 7201-7206, 2017
8. Doe, J. H. & Rowell, L. C. (2009). Coming home for Christmas: Stories about College Life (2nd ed.). R. Smith, H. G. Hernandez & C. H. Jacobs (Eds.). New York: Independent Press.
9. Zhang Y, Feng Y, Ming X, et al. Energy modulated photon radiotherapy: a Monte Carlo feasibility study[J]. BioMed Research International, 2016, 2016.
10. Jhaveri J, Cheng E, Tian S, et al. Proton vs. Photon Radiation Therapy for Primary Gliomas: An Analysis of the National Cancer Data Base. Front Oncol. 2018;8:440. Published 2018 Nov 28. doi:10.3389/fonc.2018.00440
11. Thurin, E., Nyström, P. W., Smits, A., Werlenius, K., Bäck, A., Liljegren, A., ... & Jakola, A. S. (2018). Proton therapy for low-grade gliomas in adults: A systematic review. Clinical Neurology and Neurosurgery, 174, 233-238.
12. Sai K, Yang Q Y, Shen D, et al. Chemotherapy for gliomas in mainland China: an overview[J]. Oncology letters, 2013, 5(5): 1448-1452.
13. Zwinkels H. (2019) Chemotherapy for Gliomas. In: Oberg I. (eds) Management of Adult Glioma in Nursing Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-76747-5_15
14. Sun J, Guo M, Pang H, Qi J, Zhang J, Ge Y. Treatment of malignant glioma using hyperthermia. Neural Regen Res. 2013;8(29):2775-2782. doi:10.3969/j.issn.1673-5374.2013.29.009
15. Sonabend A M, Ulasov I V, Lesniak M S. Gene therapy trials for the treatment of high-grade gliomas[J]. Gene Therapy & Molecular Biology, 2007, 11(A): 79.
16. Wu Y, Guo Y, Ma J, Sa Y, Li Q, Zhang N. Research Progress of Gliomas in Machine Learning. Cells. 2021;10(11):3169. Published 2021 Nov 15. doi:10.3390/cells10113169
17. Platten, M. (2018). Immunotherapy of Gliomas. In: Zitvogel, L., Kroemer, G. (eds) Oncoimmunology. Springer, Cham. https://doi.org/10.1007/978-3-319-62431-0_39
18. Nieder C, Grosu AL, Molls M. A comparison of treatment results for recurrent malignant gliomas. Cancer Treat Rev. 2000 Dec;26(6):397-409. doi: 10.1053/ctrv.2000.0191. PMID: 11139371.
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).